|
rs1800497
DRD2/ANKK1
Reduces dopamine D2 receptor density in the striatum, affecting reward processing, reinforcement learning, and addiction susceptibility
|
DRD2/ANKK1
|
Neurotransmitter Metabolism, Addiction & Reward Processing
|
—
|
|
rs1801133
MTHFR
Key enzyme for converting folate to its active methylfolate form
|
MTHFR
|
Methylation & Brain Nutrients
|
—
|
|
rs225014
DIO2
Affects conversion of inactive T4 to active T3 thyroid hormone in brain, pituitary, and peripheral tissues
|
DIO2
|
Neuroendocrine & Hormonal Mood
|
—
|
|
rs2802292
FOXO3
Longevity-associated intronic enhancer variant with 1.9-fold increased probability of reaching age 95
|
FOXO3
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs3892097
CYP2D6
Major enzyme for metabolizing ~25% of medications including opioids, antidepressants, and beta-blockers
|
CYP2D6
|
Psychiatric Pharmacogenomics
|
—
|
|
rs429358
APOE
Lipid metabolism and Alzheimer's risk - E4 carriers respond worse to high saturated fat
|
APOE
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs6265
BDNF
Key neurotrophin variant that controls activity-dependent BDNF release, affecting memory consolidation, neuroplasticity, and stress resilience
|
BDNF
|
Mood & Depression
|
—
|
|
rs1065852
CYP2D6
Decreased function CYP2D6 variant common in Asian populations
|
CYP2D6
|
Psychiatric Pharmacogenomics
|
—
|
|
rs11206244
DIO1
Common variant in the 3' UTR of the DIO1 gene affecting thyroid hormone metabolism and T3/T4 ratio
|
DIO1
|
Neuroendocrine & Hormonal Mood
|
—
|
|
rs17070145
WWC1
Influences episodic memory performance and hippocampal function through the KIBRA protein's role in synaptic plasticity
|
WWC1
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs1800955
DRD4
Promoter variant that modulates dopamine D4 receptor expression in the prefrontal cortex, influencing novelty seeking and cognitive flexibility
|
DRD4
|
Neurotransmitter Metabolism, Addiction & Reward Processing
|
—
|
|
rs1801131
MTHFR
Second MTHFR variant affecting enzyme activity in the regulatory domain
|
MTHFR
|
Methylation & Brain Nutrients
|
—
|
|
rs7412
APOE
APOE E2 variant - generally protective for cardiovascular health
|
APOE
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs9536314
KLOTHO
Longevity-associated variant exhibiting overdominance where heterozygotes show enhanced cognition and lifespan while homozygotes have reduced survival
|
KLOTHO
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs1051266
SLC19A1
Folate transporter — how well folate gets into your cells
|
SLC19A1
|
Methylation & Brain Nutrients
|
—
|
|
rs1611115
DBH
Strongest known genetic determinant of dopamine beta-hydroxylase activity, controlling the dopamine-to-norepinephrine ratio
|
DBH
|
Neurotransmitter Metabolism
|
—
|
|
rs1799941
SHBG
Promoter region variant affecting sex hormone-binding globulin levels, with the A allele increasing SHBG by 15-25% and influencing free testosterone and estradiol bioavailability
|
SHBG
|
Neuroendocrine & Hormonal Mood
|
—
|
|
rs2736100
TERT
Common intron 2 variant in the telomerase gene that influences telomere length, with the C allele associated with longer telomeres and increased cancer risk, while the A allele links to shorter telomeres and higher risk of degenerative diseases
|
TERT
|
Neuroinflammation & Oxidative Stress
|
—
|
|
rs4244285
CYP2C19
No-function CYP2C19 variant affecting PPIs, clopidogrel, and some antidepressants
|
CYP2C19
|
Psychiatric Pharmacogenomics
|
—
|
|
rs12248560
CYP2C19
Increased function CYP2C19 variant - rapid/ultrarapid metabolizer
|
CYP2C19
|
Psychiatric Pharmacogenomics
|
—
|
|
rs12696304
TERC
Regulatory variant near the telomerase RNA gene associated with shorter telomeres and accelerated cellular aging
|
TERC
|
Neuroinflammation & Oxidative Stress
|
—
|
|
rs2236225
MTHFD1
Folate processing enzyme — reduced stability increases choline need
|
MTHFD1
|
Methylation & Brain Nutrients
|
—
|
|
rs4570625
TPH2
Promoter variant affecting brain serotonin synthesis enzyme; influences emotional reactivity, anxiety, and depression risk
|
TPH2
|
Mood & Depression, Neurotransmitter Metabolism
|
—
|
|
rs744373
BIN1
Second strongest genetic risk factor for Alzheimer's disease after APOE, associated with increased tau pathology and accelerated cognitive decline
|
BIN1
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs11136000
CLU
Intronic variant in clusterin gene affecting Alzheimer's disease risk through regulation of amyloid-beta clearance
|
CLU
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs1801394
MTRR
B12 recycling enzyme — regenerates active B12 for the methylation cycle
|
MTRR
|
Methylation & Brain Nutrients
|
—
|
|
rs6311
HTR2A
Regulatory variant in serotonin 2A receptor gene affecting SSRI side effects and potentially treatment response
|
HTR2A
|
Mood & Depression, Psychiatric Pharmacogenomics, Neurotransmitter Metabolism
|
—
|
|
rs1805087
MTR
Methionine synthase — uses B12 to convert homocysteine to methionine
|
MTR
|
Methylation & Brain Nutrients
|
—
|
|
rs25531
SLC6A4
Promoter SNP near 5-HTTLPR that modifies serotonin transporter expression and antidepressant response
|
SLC6A4
|
Mood & Depression, Psychiatric Pharmacogenomics, Neurotransmitter Metabolism
|
—
|
|
rs743572
CYP17A1
Promoter variant affecting 17α-hydroxylase expression and steroid hormone synthesis, influencing cortisol, DHEA, androgen, and estrogen production
|
CYP17A1
|
Neuroendocrine & Hormonal Mood
|
—
|
|
rs75932628
TREM2
Rare missense variant in microglial receptor TREM2 that significantly increases late-onset Alzheimer's disease risk through impaired microglial function and amyloid clearance
|
TREM2
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs1544410
VDR
Vitamin D receptor — affects how well vitamin D activates cellular processes
|
VDR
|
Methylation & Brain Nutrients
|
—
|
|
rs1800883
HTR5A
Promoter/5' UTR variant in the serotonin 5-HT5A receptor gene affecting receptor expression, linked to schizophrenia susceptibility and executive function
|
HTR5A
|
Mood & Depression, Neurotransmitter Metabolism
|
—
|
|
rs2234693
ESR1
Estrogen receptor alpha intron variant affecting receptor expression and estrogen sensitivity
|
ESR1
|
Neuroendocrine & Hormonal Mood
|
—
|
|
rs3851179
PICALM
Variant in the PICALM gene affecting amyloid-beta clearance across the blood-brain barrier and Alzheimer's disease risk
|
PICALM
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs762551
CYP1A2
Caffeine metabolism - affects how quickly you process caffeine
|
CYP1A2
|
Sleep & Circadian Rhythm
|
—
|
|
rs10741657
CYP2R1
Vitamin D activation — converts D3 to 25(OH)D in the liver
|
CYP2R1
|
Methylation & Brain Nutrients
|
—
|
|
rs1205
CRP
3' UTR variant that modulates baseline C-reactive protein levels and inflammatory status
|
CRP
|
Neuroinflammation & Oxidative Stress
|
—
|
|
rs1800795
IL6
Promoter variant controlling interleukin-6 expression — affects inflammation, exercise recovery, and cardiovascular risk
|
IL6
|
Neuroinflammation & Oxidative Stress
|
—
|
|
rs1801260
CLOCK
Core circadian clock transcription factor variant affecting mRNA stability, associated with evening preference, delayed sleep onset, and shorter sleep duration
|
CLOCK
|
Sleep & Circadian Rhythm
|
—
|
|
rs356182
SNCA
Parkinson's disease GWAS risk variant affecting alpha-synuclein expression and neuronal differentiation
|
SNCA
|
Cognitive Health & Neurodegeneration
|
—
|
|
rs6323
MAOA
X-linked monoamine oxidase A variant affecting enzyme activity and neurotransmitter breakdown
|
MAOA
|
Mood & Depression, Neurotransmitter Metabolism, Addiction & Reward Processing
|
—
|
|
rs1360780
FKBP5
Co-chaperone of the glucocorticoid receptor that regulates cortisol feedback — the T allele impairs stress recovery and, combined with early adversity, strongly increases risk of PTSD and depression
|
FKBP5
|
Anxiety & Stress Response
|
—
|
|
rs16944
IL1B
Promoter variant affecting IL-1 beta production, influencing inflammatory response and cardiovascular disease risk
|
IL1B
|
Neuroinflammation & Oxidative Stress
|
—
|
|
rs228697
PER3
Core clock gene variant that shifts circadian period length and influences morning vs evening chronotype
|
PER3
|
Sleep & Circadian Rhythm
|
—
|
|
rs7946
PEMT
Phosphatidylcholine production — affects dietary choline requirements
|
PEMT
|
Methylation & Brain Nutrients
|
—
|
|
rs2304672
PER2
Regulatory variant in a core clock gene that influences circadian timing, sleep-wake preference, and reward processing
|
PER2
|
Sleep & Circadian Rhythm
|
—
|
|
rs4680
COMT
Dopamine/catecholamine breakdown — affects stress response and methyl donor tolerance
|
COMT
|
Anxiety & Stress Response, Neurotransmitter Metabolism, Methylation & Brain Nutrients
|
—
|
|
rs53576
OXTR
Most-studied oxytocin receptor variant, influencing empathy, social sensitivity, stress resilience through social buffering, and emotional regulation
|
OXTR
|
Mood & Depression, Anxiety & Stress Response
|
—
|
|
rs10830963
MTNR1B
Melatonin receptor variant that extends nighttime melatonin signaling in pancreatic beta cells, impairing glucose-stimulated insulin secretion — especially when meals are eaten late
|
MTNR1B
|
Sleep & Circadian Rhythm
|
—
|
|
rs234706
CBS
Common synonymous variant in the CBS gene associated with reduced cardiovascular disease risk and enhanced response to folate supplementation
|
CBS
|
Methylation & Brain Nutrients
|
—
|